TIVDAK is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Seagen Inc.. The primary component is Tisotumab Vedotin.
Product ID | 51144-003_0c677307-7c46-4bb4-a568-4435271c38ab |
NDC | 51144-003 |
Product Type | Human Prescription Drug |
Proprietary Name | TIVDAK |
Generic Name | Tisotumab Vedotin |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-09-20 |
Marketing Category | BLA / |
Application Number | BLA761208 |
Labeler Name | Seagen Inc. |
Substance Name | TISOTUMAB VEDOTIN |
Active Ingredient Strength | 1 mg/mg |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-09-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() TIVDAK 97387050 not registered Live/Pending |
Seagen Inc. 2022-04-28 |
![]() TIVDAK 88983161 not registered Live/Pending |
SEAGEN INC. 2018-09-25 |
![]() TIVDAK 88130645 not registered Live/Pending |
Seattle Genetics, Inc. 2018-09-25 |